Fosaprepitant - Nausea and vomiting (chemotherapy induced)

You are here : Home > Formulary Search > Fosaprepitant - Nausea and vomiting (chemotherapy induced)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Intravenous infusion

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

SPC

Restrictions / Comments :

Important

RSCH Oncology Team only

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Fosaprepitant

Indication :

Nausea and vomiting (chemotherapy induced)

Group Name :

Keywords :

Brand Names Include :

Ivemend

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Fosaprepitant is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Nausea and vomiting (chemotherapy induced).